Filing Details
- Accession Number:
- 0001093557-24-000182
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-18 16:12:01
- Reporting Period:
- 2024-11-15
- Accepted Time:
- 2024-11-18 16:12:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1681267 | M Jereme Sylvain | 6340 Sequence Drive San Diego CA 92121 | Evp, Chief Financal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-11-15 | 3,500 | $75.51 | 80,774 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- On November 21, 2023, Mr. Sylvain adopted a 10b5-1 Plan which was amended on August 6, 2024. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sylvain. The shares set forth abovewere sold pursuant to the 10b5-1 Plan.
- Included in this number are 49,085 unvested restricted stock units, 26,053 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 7,060 of which were granted on March 8, 2022 and shall vest through March 8, 2025, and 1,460 of which were granted on December 15, 2021 and shall vest through December 15, 2024.